Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
2023 · European Urology · 118 citations
https://doi.org/10.1016/j.eururo.2023.06.006
S
Satoshi Tamada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
6.7K
Citations
26
h-index
48
i10-index
Satoshi Tamada is an academic researcher from Osaka Prefecture University. The author has contributed to research in topics: Renal cell carcinoma treatment & Prostate Cancer Treatment and Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 26, co-authored 106 publications.
ORCID: 0000-0002-7102-3408Papers by this author
worksOutcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction
2017 · International Journal of Urology · 34 citations
https://doi.org/10.1111/iju.13500
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study
2021 · International Journal of Clinical Oncology · 25 citations
https://doi.org/10.1007/s10147-021-02014-7
Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents
2018 · Cancer Management and Research · 22 citations
https://doi.org/10.2147/cmar.s172283
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial
2025 · Nature Medicine · 22 citations
https://doi.org/10.1038/s41591-025-03867-5
Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study
2014 · World Journal of Urology · 19 citations
https://doi.org/10.1007/s00345-014-1399-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat